HYLORIS PHARMACEUTICALS SA NPV revenue for the last year amounted to 4.40 M EUR, the most of which — 2.09 M EUR — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 2.95 M EUR. The greatest contribution to the revenue figure was made by Belgium — last year it brought HYLORIS PHARMACEUTICALS SA NPV 2.09 M EUR, and the year before that — 2.95 M EUR.